Cetera Investment Advisers
ANIK icon

Cetera Investment Advisers’s Anika Therapeutics ANIK Stock Holding History

Cetera Investment Advisers’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Sell
10,572
-3,648
-26% -$54.1K ﹤0.01% 4561
2026
Q1 		$206K Sell
14,220
-2,235
-14% -$25.9K ﹤0.01% 4267
2025
Q4 		$158K Sell
16,455
-4,605
-22% -$44.1K ﹤0.01% 4290
2025
Q3 		$198K Buy
21,060
+1,551
+8% +$14.8K ﹤0.01% 4159
2025
Q2 		$206K Buy
19,509
+9,407
+93% +$119K ﹤0.01% 3706
2025
Q1 		$152K Buy
+10,102
New +$168K ﹤0.01% 3677

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Cetera Investment Advisers's ANIK Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Anika Therapeutics (ANIK) stake by 26% in Q2 2026, selling an estimated $54.1K and leaving 10,572 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #4561.

Cetera Investment Advisers first reported a position in ANIK in Q1 2025 and has held it in 6 quarters since. The position peaked at $206K in Q2 2025. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Cetera Investment Advisers held 10,572 shares of Anika Therapeutics worth $155K as of Q2 2026.
  • Cetera Investment Advisers sold 3,648 Anika Therapeutics shares in Q2 2026, an estimated $54.1K.
  • Anika Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4561 holding.
  • Cetera Investment Advisers first reported a position in Anika Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Cetera Investment Advisers's Anika Therapeutics position peaked at $206K in Q2 2025.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.